| 21 Nov 2008 |
|
UAE: Experts Seek More Research for Effective Medicines
- Text size
Dubai - Local medical experts have called for more health research at the regional level to make new drugs more effective for patients.
The call comes close on the heels of a new study which showed that a new drug had helped reduce major cardiovascular (CV) diseases significantly.
Dr Abdullah Shehab, Director of Continuing Medical Education, Emirates Society of Cardiology, said consistent and ongoing research in cardiology was essential, so that it takes into consideration the peculiar traits and habits of the local population.
"International research is important, but we need to know better our people's status. Private and public sectors should join forces to conduct more research. Clinical research related to specific cases is completely absent in the GCC region," he said on Wednesday.
Recently, new data from the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study has demonstrated that the medicine Rosuvastatin had significantly reduced major cardiovascular events (defined in this study as the combined risk of myocardial infarction, stroke, arterial revascularisation, hospitalisation for unstable angina, or death from CV causes).
Dr Afzalhussein Yusufali, consultant cardiologist, Dubai Hospital, said: "This is a landmark study and will change the way we practice medicine in the future.
asmaalizain@khaleejtimes.com
© Khaleej Times 2008
Zawya is a distributor (and not a publisher) of content supplied by third parties and subscribers. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by those third parties, including information providers, subscribers or other users of the Service, are those of the respective author(s) or distributor(s) and not of the Company. The Company neither endorses nor is responsible for the accuracy or reliability of any opinion, advice or statement made on the Service by anyone other than authorized Service employee spokespersons while acting in their official capacities. The Company is not responsible for any infringement of intellectual property rights or breach of any applicable law or regulation, including regulation in relation to financial services or the distribution of financial products, defamation, data protection, telecommunications (including regulations relating to excessive use, spamming or other abusive activities) or obscene, offensive or illegal content). Under no circumstances will the Company be liable for any loss or damage caused by a member's reliance on information obtained through the Service. It is the responsibility of member to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content available through the Service. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content.
Read the full Member Agreement
http://www.zawya.com/legal/NewsLetter.cfm?name=disclaimer
Loading ...
Post a Comment
1.1 Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
1.2 Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
1.3 Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
1.4 Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
1.5 Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
1.6 Give the impression that they represent Zawya.
1.7 Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse.